YOLARX is a consulting and research organization that provides expertise and research in real-world investigation of disease epidemiology, drug utilization, safety and effectiveness, risk management planning, including strategy, feasibility assessment, study design and conduct, data analysis and medical writing. Projects that we are involved in support the demonstration of product value to achieve patient access and/or regulatory approval.
Our mission is to provide expertise and research of the highest methodological standards that evaluate the benefits and harms of medicines in the real-world, for a global client base.
YOLARX Consultants consists of two entities: YOLARX Consultants INC, a Quebec registered company created in 2006, and YOLARX Consultants SARL in Paris, France (created in 2015). YOLARX is comprised of academic health researchers and of professionals with extensive experience in the conduct of real-world investigations, including natural history of diseases and unmet needs, non-interventional studies, post-authorization studies (PAS), and pharmacovigilance/risk management. With a global client base, YOLARX Team is international and is able to conduct research in a large number of local languages. YOLARX is featured in the ENCePP Database of Research Resources at the European Medicines Agency (EMA).
Our service offering is divided into three pillars of activities:
1. Safety & Effectiveness Evaluation: Generating real-world evidence using administrative claims databases, electronic health records, registries and ad hoc data collection; synthesizing the evidence through systematic reviews and meta-analysis.
2. Therapeutic Risk Management: State-of-the-art studies including drug utilization studies, knowledge and understanding surveys, implementation of risk minimization interventions, as well as their effectiveness assessment.
3. Pharmacovigilance: From spontaneous reporting to data mining, active surveillance, case population studies, case series, and benefit-risk analysis, safety assessment strategy and methods.
For additional information about our company and our services, please visit our website at: www.yolarx.com.